Interventional glaucoma: Redefining the optometrist’s role in modern glaucoma management | Optometry Times - Clinical News

Published on November 6, 2025
A shift toward minimally invasive, evidence-based interventions is redefining standards of care.
Continue reading on website
Other news

FDA Approves XDEMVY 0.25% for the Treatment of Demodex Blepharitis

November 6, 2025
IRVINE, Calif.—Tarsus Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) approved XDEMVY (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis.

Dry eye disease prevalence increases following menopause

November 6, 2025
A presentation at the annual meeting of The Menopause Society in Orlando, Florida examined the relationship between menopause and dry eye disease